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NANOPARTICLES FOR 
CANCER THERAPY
Tuning Their Shape, Size, and Material using Computer Simulations
Kaspar Haume, Department of Physical Sciences, Open University
This project is part of  the ARGENT consortium - a Marie Curie funded international project 
with a total of  13 early stage researchers across Europe working together with academia and 
industry.
See more on www.itn-argent.eu
THE PROBLEM
More than 50% of  all cancer patients receive ra-
diotherapy which largely means X-ray therapy. 
X-rays kill cells by the deposition of  energy 
(the “dose”) into the cells, but unfortunately 
these X-rays also damage healthy cells.
Furthermore, radiation is introduced from 
many angles to increase the dose on the tu-
mor leading to irradiation of  much more 
healthy tissue than strictly necessary - this 
can be detrimental, especially for brain tum-
ors (see image).
Therefore what is needed is a new therapy 
that allows more targeted application of  the radi-
ation to reduce damage to healthy cells.
THE SOLUTION
Nanoparticles (particles less than 10 nanometres wide) have been 
shown to increase the effect of  the radiation. This means that less 
radiation can be used while still achieving the same therapeutic ef-
fect. 
Less overall radiation => less damage to healthy tissue ! 
Nanoparticles are regarded as the next 
generation of  radiotherapy agents,
but the method by which they sen-
sitize radiation is complex and 
more research is needed to un-
derstand the process and tailor 
the nanoparticles. 
MY PROJECT
As part of  a large European project (ARGENT) to explore and develop the use of  nano-
particles as the next generation radiotherapeutic agents, I am designing computer simula-
tions to simulate the interaction between nanoparticles, radiation, and cells.
I will be using Molecular Dynamics and Density Functional Theory for the simulations.
 
The goal is to find the best shape, size, and material of  nanoparticles that will allow them to be 
successfully incorporated into the tumor cells and increase tumor cell death through irradiation by 
conventional (X-rays) and next generation radiation (e.g. carbon ions) therapy.
TRUSTING COMPUTERS
A major concern in using computer simulations is whether the 
computer model is realistic. Therefore in my project I have to show 
that the model matches reality ! 
The first step is to be sure that the simulation creates realistic-looking nanoparticles. 
This is done by modeling the structure of  the nanoparticle which in physics par-
lance means computing the most stable energy configuration. 
Here, I compare my nanopar-
ticles with those previously 
computed and stored in The 
Cambridge Cluster Database - 
an online collection of  optimal 
structures of  nanoparticles of  
different sizes. 
A LITTLE EXTRA ON TOP
Nanoparticles can be guided to cancer cells by attaching specific 
molecules onto their surface. This also helps avoid strong immune 
defense reactions to the nanoparticles.
 
A key part of  the ARGENT project (with experiments being 
performed at the OU) is to determine the best molecules to 
attach to nanoparticles. 
Since experimental trial and error is timely (and 
expensive) computer simulations provide 
a tool for exploring many different 
options. One example, shown here, 
is the molecule DTDTPA (an or-
ganic acid) attached to a small 
gold nanoparticle.  
